1 Enspring 120mg Subcutaneous Auto-Injector, 20 Units
Sole-source noticeJapanese title: 1 エンスプリング皮下注120mgオートインジェクター20本
Overview
Procurement of 20 units of Enspring 120mg subcutaneous auto-injectors by National Hospital Organization Osaka Toneyama Medical Center. The contract is planned as a single tender due to lack of competition for technical reasons. The scheduled contract date is November 30, 2026.
Key Details
- Source: Kanpo
- Notice type: Sole-source notice
- Publication date: November 4, 2026
- Procuring entity: National Hospital Organization Osaka Toneyama Medical Center
- Planned contract date: November 30, 2026
- Intended vendor: Mediceo Corporation
- Status: Active
- Technology relevance: Possible
- Business-action likelihood: Medium – The procurement is a single tender to Mediceo Corporation due to technical reasons, indicating limited competition and potential barriers for new entrants.
Official Notice
Official Source
Kanpo, Japan's official government gazette, in which legally required public procurement notices are formally published.
- Source: Kanpo, Government Procurement Notice Edition
- Official category: Sole-source procurement notice
- Publication date: November 4, 2026
- Publication: Kanpo, pages 37
Full English Translation
The following English translation was prepared from the original Japanese notice published in Kanpo. Where an official English summary appears in the Kanpo publication, it was used only for verification; the translation below is based on the Japanese source text.
1 Procurement details:
(1) Item classification number 4
(2) Procurement subject and quantity: 1 Enspring subcutaneous 120mg auto-injector, 20 units.
2 Scheduled date of single tender contract:
November 30, 2026.
3 Reason for single tendering under the Agreement on Government Procurement:
b "No competition due to technical reasons." 4 Name of the party planned for single tender contract: Mediceo Corporation.
5 Contact:
Planning Division, Contract Section, National Hospital Organization Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka City, Osaka 560-8552, Phone 06-6853-2001 ext. 7306.
Show original Japanese notice
随意契約に関する公示
次のとおり随意契約について公示します。令和8年11月4日経理責任者独立行政法人国立病院機構大阪刀根山医療センター院長望月秀樹◎調達機関番号597 ◎所在地番号271 調達内容(1)品目分類番号 4(2)購入等件名及び数量 1エンスプリング皮下注120mgオートインジェクター20本2 随意契約の予定日 令和8年11月30日3 随意契約によることとする「政府調達に関する協定」の規定上の理由 b「技術的理由による競争の不存在」4 随意契約を予定している相手方の名称 1株式会社メディセオ5 問合せ先 〒560-8552 大阪府豊中市刀根山5-1-1独立行政法人国立病院機構大阪刀根山医療センター企画課契約係 電話06- 6853-2001内線7306
Business Signal
Business Relevance
Use this notice for preparation or market research; it does not establish an open opportunity to submit a bid now.
- Product fit: Potential
- Current-case feasibility: Not applicable
- Evidence confidence: Low
- Supply-chain security: Unknown
Participation fit
This procedure is classified as sole-source and is not an open competitive tender. Direct participation is not applicable, but the notice may indicate existing government demand and active relevant vendors in Japan.
JBid analysis. Interpretations and questions below do not establish procurement requirements; consult the official documents for those requirements.
This page is based on the official Kanpo tender notice, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.
JBid is a beta technology-procurement intelligence service by I.J. Do.